SCHEMBL25525874

SCHEMBL25525874

C[N+](C)(C)CCC[n+]1ccc(/C=C/c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.38
CHRM4 P08173 2/20 0.38
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
CHAT P28329 3/20 0.35
KDM4A O75164 2/20 0.34
KDM2A Q9Y2K7 2/20 0.34
APP P05067 1/20 0.34
MEN1 O00255 2/20 0.31
USP2 O75604 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
MAPK1 P28482 1/20 0.31
CTNNB1 P35222 1/20 0.31
ATM Q13315 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL25238589 0.99 CHRM2 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25238588 0.99 CHRM2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25238587 0.99 CHRM2 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL25525863 0.93 CHRM2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25211054 0.92 CHRM2 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25266852 0.92 CHRM2 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25266851 0.92 CHRM2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL25525887 0.90 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25205717 0.89 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL25267190 0.89 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165978-A1 Composition and A Method For Diagnosing And Treating Bacterial Infection Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited (HK) 2023-06-01 US disclosed
US-20230165978-A1 Composition and A Method For Diagnosing And Treating Bacterial Infection Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited (HK) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165978-A1 Composition and A Method For Diagnosing And Treating Bacterial Infection NOD2, PYCARD, NOD1 CHRM2 3603/4885CHRM4 3521/4885CHRM5 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.